ReviewTranslational lung cancer research2021

Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease.

Francesco Passiglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.